One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.
University of Copenhagen researchers have developed a prototype patch for treating plaque psoriasis, which may simplify ...
A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...
Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...
Discover a recent study from 12 hospitals across China that has shed new light on personalised care for plaque psoriasis.
Alumis’ most advanced product candidate, ESK-001, is an oral, highly selective, small molecule, allosteric inhibitor of tyrosine kinase 2 that is currently being evaluated for the treatment of ...